Choosing the Right Commercial Test Kit: Why Performance Claims Alone Are Not Enough
Introduction
Commercial ELISA, real-time PCR, and rapid screening kits are often selected based on performance claims, detection limits, and marketing literature. Yet many laboratories discover during implementation that a method performing well on paper does not always perform well in practice.
Commercial analytical kits have become essential tools in modern food testing laboratories. Whether testing for allergens, GMO events, animal species, or food authenticity markers, laboratories are increasingly reliant on commercially available solutions to meet client expectations and regulatory requirements.
However, selecting a kit based solely on manufacturer specifications can create significant technical and operational risk. A method that performs exceptionally well under controlled development conditions may not perform as expected within a laboratory's specific matrices, workflows, accreditation requirements, or testing objectives.
Choosing the right kit requires a structured, evidence-based evaluation that considers analytical performance, matrix suitability, regulatory expectations, fitness for purpose, and practical implementation realities.
Why Kit Selection Matters
Poor kit selection is rarely an inexpensive mistake. The consequences can include false positive or false negative results, failed validation or verification studies, accreditation challenges, prolonged investigations, implementation delays, and client disputes.
The true cost of implementing an unsuitable method often far exceeds the purchase price of the kit itself. Investing time in a robust evaluation process before implementation is usually the most economical and scientifically defensible approach.
Consider a laboratory implementing a commercial allergen ELISA kit for a high-fat confectionery matrix. Although the kit demonstrated excellent performance during manufacturer validation, local recovery studies revealed significant matrix interference that required optimisation before routine use. Situations such as this are not uncommon and highlight the importance of fit-for-purpose verification.
Qualitative Versus Quantitative Kits
Before evaluating any commercial kit, it is important to determine whether the testing requirement is qualitative or quantitative.
Qualitative methods are designed to determine the presence or absence of a target analyte relative to a defined decision point. Their performance is typically assessed through detection capability, specificity, and false positive and false negative rates.
Quantitative methods are designed to estimate concentration and therefore require additional performance characteristics such as accuracy, precision, linearity, measurement uncertainty, and traceability to suitable calibration standards or reference materials.
Applying quantitative performance expectations to a qualitative assay, or vice versa, can result in inappropriate evaluation criteria and misleading conclusions regarding method suitability.
Looking Beyond Sensitivity
Sensitivity is often the first specification reviewed when comparing commercial kits. While sensitivity is important, it should not be the sole or dominant selection criterion.
Other critical performance characteristics include:
Specificity
Cross-reactivity profile
Matrix compatibility
Precision and reproducibility
Robustness under routine laboratory conditions
Ease of implementation
Technical support
Regulatory acceptance
The most sensitive method is not necessarily the most suitable method. A highly sensitive assay with poor specificity or significant cross-reactivity may create more challenges than it resolves.
Matrix Effects: The Hidden Challenge
Food matrices are analytically complex systems. Fats, proteins, salts, polyphenols, spices, fermentation products, and processing-derived compounds can significantly influence analytical performance.
Matrix-related effects such as inhibition, signal suppression, extraction inefficiencies, and non-specific binding may not be fully represented during manufacturer validation studies conducted under controlled conditions.
A method demonstrated to perform well in one matrix cannot automatically be assumed to perform equally well in another. Laboratories should evaluate kit performance using representative matrices within their own scope of testing before committing to routine implementation.
Reading the Instructions for Use Carefully
The manufacturer's Instructions for Use (IFU) is the primary technical reference document for any commercial assay.
The IFU defines:
Intended use
Validated matrices
Analytical range
Known cross-reactivities
Storage conditions
Quality control requirements
Method limitations
Unfortunately, IFUs are sometimes treated as background documentation rather than technical specifications.
This can create significant risk. For example, applying a kit to a matrix not included within the validated scope of the IFU may require additional verification studies before routine use can be justified.
Manufacturer Validation Versus Laboratory Verification
One of the most common misconceptions in laboratory testing is the assumption that manufacturer validation eliminates the need for laboratory verification.
These activities serve different purposes.
Manufacturer validation demonstrates that a method can achieve specified performance characteristics under defined conditions.
Laboratory verification confirms that the same method performs as expected within the laboratory's own environment, using its personnel, equipment, workflows, and matrices.
The two processes are complementary rather than interchangeable.
Even when a commercial method has undergone extensive manufacturer validation, laboratories remain responsible for demonstrating fitness for purpose within their own testing context.
Verification Before Routine Use
Commercial kits should undergo fit-for-purpose verification before introduction into routine accredited testing programs.
Verification activities may include:
Precision studies
Recovery assessments
Matrix evaluations
Specificity testing
Cross-reactivity assessments
Detection capability confirmation
The extent of verification should be proportionate to the intended application and the risk profile associated with the analyte being measured.
Verification provides confidence that a method performs as expected under local laboratory conditions rather than relying solely on external validation data.
Regulatory and Accreditation Requirements
Laboratories operating under ISO/IEC 17025 accreditation, including those accredited by NATA in Australia, are required to verify commercially sourced methods before use.
The standard requires laboratories to demonstrate that methods are fit for their intended purpose and perform as expected within their own operational environment.
It is important to recognise that purchasing a kit from a reputable supplier does not satisfy this obligation. Similarly, the existence of accredited validation data generated elsewhere does not remove the laboratory's responsibility to generate evidence supporting local implementation.
Where commercial kits are used to support regulatory decisions, additional considerations may include traceability, detection capability, reporting thresholds, and documentation requirements.
Kit Equivalence and Method Comparison
When laboratories consider replacing an existing commercial kit or comparing a commercial assay with an in-house or reference method, formal equivalence assessment is recommended.
Side-by-side comparisons using representative sample sets provide valuable information regarding method agreement and practical performance differences.
The sample set should ideally include naturally contaminated materials alongside spiked samples where appropriate.
Agreement criteria should be established before testing begins, and any discordant results should be investigated before implementation decisions are made.
Even when replacing a kit with a newer version from the same manufacturer, performance equivalence should not be assumed.
Lot-to-Lot Variability and Supply Chain Considerations
Commercial assays are manufactured in production batches, and performance can vary between lots.
Changes in antibodies, reagents, calibrators, or manufacturing processes may result in subtle but important performance differences.
Laboratories should establish procedures for assessing new kit lots before routine implementation. This may include the use of retained quality control materials or reference samples to confirm acceptable performance.
Supply chain reliability should also be considered during kit selection. A technically excellent assay may still present operational challenges if availability is inconsistent, shelf life is limited, or backorders are common.
Reference Standards and Positive Controls
Ongoing method performance monitoring requires more than simply running kit-provided controls.
Where available, independently sourced reference materials or certified reference materials provide a more objective assessment of long-term assay performance.
Manufacturer controls are important but are often validated against the supplier's own production system. Independent quality control materials can provide an additional layer of assurance and may be more sensitive to subtle performance changes or reagent drift.
Laboratories should establish acceptance criteria based on historical performance data and routinely monitor trends over time.
Conclusion
Successful kit selection is ultimately about fitness for purpose. The objective is to identify a method that meets analytical requirements, performs reliably within target matrices, satisfies accreditation and regulatory expectations, and can be supported operationally over the long term.
Performance claims and detection limits should be viewed as a starting point rather than a conclusion. The true assessment of suitability occurs during method evaluation, matrix-specific verification, and ongoing performance monitoring.
The most successful laboratories do not select methods based solely on manufacturer claims. They select methods based on evidence generated within their own environment, matrices, and intended applications.
Verification is not merely an accreditation requirement. It is the process that transforms a commercial kit into a scientifically defensible analytical method.
Contact PN Scientific Consulting to ensure your selected testing method is fit for purpose, scientifically defensible, and aligned with your laboratory's accreditation requirements.
